Furthermore, recurrent somatic DNMT3A mutations have been identified in acute myeloid leukemia and other hematological malignancies [33–35], indicating that impaired activity of DNMT3A is a causal factor of tumorigenesis. Here, DNMT3A is linked to hematologic disorder.